Larvol Delta - Equillium-Presents-Positive-Data-from-Phase-1b-EQUALISE-Study-at-the-2023-Annual-Meeting-of-the-American-College-of-Rheumatology

Alzumab (itolizumab) - Biocon, Equillium, Ono Pharma

https://www.businesswire.com/news/home/20231113802828/en/Equillium-Presents-Positive-Data-from-Phase-1b-EQUALISE-Study-at-the-2023-Annual-Meeting-of-the-American-College-of-Rheumatology

Nov 13, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next